データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
942619-79-6Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(OP(=O)([O-])[O-])c3cc(Cl)ccc32)c(C)c1.[Na+].[Na+]942619-79-6説明Tolvaptan sodium phosphate (trade name Samtasu) is a selective small molecule vasopressin V2 receptor antagonist developed by Otsuka Pharmaceutical Co., Ltd. Tolvaptan sodium phosphate is a prodrug form of generic tolvaptan (7.13) with improved water solubility. The drug was approved by the Japanese PMDA in March 2022 for the treatment of patients with fluid retention who have difficulty taking tolvaptan orally.
現在のフィルター条件では反応記録がありません。
読み込み中…